{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:39Z","timestamp":1793766459224,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102627","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:09:01Z","timestamp":1784934541000},"page":"102627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Parsa","family":"Iranmahboub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6367-2854","authenticated-orcid":false,"given":"Priya","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5698-2169","authenticated-orcid":false,"given":"Joshua","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1989-1367","authenticated-orcid":false,"given":"Helen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Angulo-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon Malik","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5265-336X","authenticated-orcid":false,"given":"Evan","family":"Suzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Scherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clgc.2026.102627_bib0001","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.euf.2018.08.010","article-title":"Unmet clinical needs and future perspectives in non\u2013muscle-invasive bladder cancer","volume":"4","author":"Campi","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"17","key":"10.1016\/j.clgc.2026.102627_bib0002","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2026.102627_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","article-title":"Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","volume":"55","author":"Shabsigh","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102627_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","article-title":"A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer","volume":"25","author":"Yang","year":"2016","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102627_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 Amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.clgc.2026.102627_bib0006","first-page":"796.e1","article-title":"Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members","volume":"38","author":"Matulay","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1\u20132","key":"10.1016\/j.clgc.2026.102627_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5489\/cuaj.3143","article-title":"Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta","volume":"10","author":"Gotto","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clgc.2026.102627_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.urology.2018.07.055","article-title":"Utilization of Bacillus Calmette-Guerin for nonmuscle invasive bladder cancer in an era of Bacillus Calmette-Guerin supply shortages","volume":"124","author":"Khanna","year":"2019","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.clgc.2026.102627_bib0009","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102627_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102627_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.6004\/jnccn.2026.0022","article-title":"Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology","volume":"24","author":"Flaig","year":"2026","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.clgc.2026.102627_bib0012","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11912-025-01657-3","article-title":"Current State of bladder preservation in high grade non-muscle invasive bladder cancer and localized muscle invasive bladder cancer","volume":"27","author":"Popli","year":"2025","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.clgc.2026.102627_bib0014","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.eururo.2025.05.005","article-title":"Management dilemma for very high-risk non-muscle-invasive bladder cancer: real-world data challenge the guideline recommendation for upfront radical cystectomy","volume":"88","author":"Subiela","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2026.102627_bib0015","first-page":"S54","article-title":"Us clinical practice patterns of intravesical chemotherapy for Bcg-unresponsive non-muscle invasive bladder cancer among carcinoma in situ and papillary-only tumors","volume":"42","author":"Chakra","year":"2024","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.clgc.2026.102627_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12894-022-00959-z","article-title":"Multi-country clinical practice patterns, including use of biomarkers, among physicians\u2019 treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)","volume":"22","author":"Broughton","year":"2022","journal-title":"BMC Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102627_bib0017","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.clgc.2020.03.013","article-title":"Quantifying the overall survival benefit with early radical cystectomy for patients with histologically confirmed T1 non\u2013muscle-invasive bladder cancer","volume":"18","author":"Tully","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102627_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000499257","article-title":"Survival outcomes of early versus deferred cystectomy for high-grade non-muscle-invasive bladder cancer: a systematic review","volume":"14","author":"Wan","year":"2020","journal-title":"Curr Urol"},{"issue":"15","key":"10.1016\/j.clgc.2026.102627_bib0019","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.3390\/cancers14153797","article-title":"Effectiveness of early radical cystectomy for high-risk non-muscle invasive bladder cancer","volume":"14","author":"Diamant","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2026.102627_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euros.2023.04.013","article-title":"Bladder-sparing treatment in patients with Bacillus Calmette-Guerin\u2013unresponsive non\u2013muscle-invasive bladder cancer: an analysis of long-term survival outcomes","volume":"53","author":"Tan","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"10.1016\/j.clgc.2026.102627_bib0021","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bju.16509","article-title":"Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer","volume":"135","author":"Taylor","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2026.102627_bib0022","doi-asserted-by":"crossref","unstructured":"Scilipoti P, Longoni M, Angelis M de, et al. Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer. BJU Int 136(1):47\u201354. doi:10.1111\/bju.16675","DOI":"10.1111\/bju.16675"},{"issue":"2","key":"10.1016\/j.clgc.2026.102627_bib0023","article-title":"New treatment options for non-muscle-invasive bladder cancer","volume":"45","author":"Filon","year":"2025","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"issue":"3","key":"10.1016\/j.clgc.2026.102627_bib0024","first-page":"69.e11","article-title":"Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy","volume":"42","author":"McFadden","year":"2024","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"6","key":"10.1016\/j.clgc.2026.102627_bib0025","first-page":"275.e1","article-title":"Histological variants of non\u2013muscle invasive bladder cancer: survival outcomes of radical cystectomy vs. bladder preservation therapy","volume":"40","author":"Dursun","year":"2022","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"6","key":"10.1016\/j.clgc.2026.102627_bib0026","doi-asserted-by":"crossref","first-page":"308.e11","DOI":"10.1016\/j.urolonc.2018.03.007","article-title":"Improved surgical outcomes following radical cystectomy at high-volume centers influence overall survival","volume":"36","author":"Scarberry","year":"2018","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102627_bib0027","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.urology.2011.02.042","article-title":"Ethnic differences in bladder cancer survival","volume":"78","author":"Yee","year":"2011","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clgc.2026.102627_bib0028","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cam4.4917","article-title":"Racial inequity and other social disparities in the diagnosis and management of bladder cancer","volume":"12","author":"Hasan","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.clgc.2026.102627_bib0029","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.28416","article-title":"Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","volume":"120","author":"Cohn","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102627_bib0030","first-page":"120.e1","article-title":"Disparities and temporal trends in referral for bladder cancer diagnosis: a worsening epidemic","volume":"44","author":"Myers","year":"2026","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"10.1016\/j.clgc.2026.102627_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou","year":"2012","journal-title":"Eur Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:16:41Z","timestamp":1793765801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001278"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102627","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102627"}}